Abstract:Interferon alpha are used in clinic to treat a variety of viral diseases and cancers.They have short circulating half-life,which necessitates frequent administration to patients.Previous studies showed that it is possible to extend the circulating half-life of interferon alpha by modifying cysteine residues of the protein with poly(ethylene glycol)(PEG) reagents.But protein seldom have unpaired-SH,so a free cysteine residue was introduced into the protein by recombinant DNA technique and only 1% activity was retained after pegylation.So a proper position should be selected for pegylation and enhance the retained activity.Integrated interferon(IIFN) has a wide variety of biological effects that include viral inhibition,antiproliferation,and immunomodulation.Aspartate residue at positon of 72 was chosed by homology sequence analysis and space structure simulation methods.Integrated interferon mutant Cys72(IIFN_(72C)) was a cysteine mutant of IIFN.The protein had higher specific activity and may used for site-directed modified by PEG.It was constructed by substitution of Asp at position 72 with Cys using site-directed mutagenesis.The DNA was constructed in pET-23b expression vector,and transformed into E.coli BL21(DE3).IIFN_(72C) was expressed as inclusion bodies with yield of more than 30% of total bacterial protein.The recombinant protein was expressed by auto-induction and purified by DEAE Sepharose FF and Chelating Sepharose FF column chromatography.After purification,the protein was modified with a 20kDa mPEG-maleimide and the mono-PEGylated protein was separated from unmodified IIFN_(72C) by stepwise elution.After purification,the purity of mono-PEG-IIFN_(72C) was up to 98%,and the biological activity was more than 3×10~7 IU/mg,The retained activity was up to 8%,which higher than before.These results confirmed the utility of site-specific PEGylation for creating long-acting interferon with higher activity.

Structure and Function of Mono-PEGylated Recombinant Human Interferon Omega

[Preparation and Characterization of Mono PEGylated Recombinant Human Interferon Omega].

Study on Characterization of PEGylated and Native Consensus Interferon Α

Physiological and Chemical Characteristics of Recombinant Human Interferon Α2b Modified with Polyethylene Glycol

Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics

Construction, Expression, Purification and Site-specific PEGylation of Integrated Interferon Mutant Cys72

Hydrophilic Biodegradable Microspheres of Interferon-Alpha and Its Pharmacokinetics in Mice.

Molecular Insights into the Improved Bioactivity of Interferon Conjugates Attached to a Helical Polyglutamate

[High-level expression behaviors of recombinant human interferon omega in logarithm phrase Pichia pastoris].

Pegylation and Cell Based Bioassay of Human Interferon-Α2b along Its Docking Studies and Effect on Plasma Half-Life.

RP-HPLC determination of recombinant human interferon omega in the fermentation broth

[Preparation and Identification of Recombinant Human Interferon-Gamma].

Expression and Purification of Human Interferon-ω in Yeast Pichia Pastoris

Studies on the Pegylation of Protein at A Specific Site: Sulfhydryl-Pegylation of 97Cys-Ifn-gamma

Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs

The application of HPLC/MS analysis with a multi-enzyme digest strategy to characterize different interferon product variants produced from Pichia pastoris

Quality Control Methods for PEG-IFNα2b

Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Purification of Recombinant Porcine-α Interferon and the Identification of its Biochemical Characteristics

In vitro Nitration and Oxidation of Recombinant Human Interferon alpha 2b by Peroxynitrite

PEGylation of Human Interferon-Α2b with Modified Amino Acids Increases Circulation Half-Life and Antiproliferative Activity